Contact UsInvestorsCareersMediaScienceContact Us


HomeScienceOur Therapy AreasAnti-infectives


Anti-infectives are medicines such as antibiotics, antifungals, and antivirals that work to treat or prevent infections.

Since the 1940’s when Pfizer first mass-produced penicillin, we’ve been actively involved in the discovery and development of medicines to treat infections as well as vaccines that prevent them.

We have over 80 anti-infective medicines and vaccines in our portfolio, and continue to evaluate opportunities to expand our R&D pipeline to ensure we address the evolving medical needs of patients and healthcare workers. This includes helping to tackle antimicrobial resistance (AMR), where micro-organisms which cause infection (e.g. bacteria) survive exposure to a medicine that would normally kill them or stop their growth.

Related Content

'Superbugs: Join the Fight’ school programme 

Raising awareness of antimicrobial resistance, viruses & pandemics, and the role of vaccines in schools across the UK.

Hope on the horizon: why it’s not too late for antimicrobials

Antimicrobial resistance (AMR) is one of the top global threats facing society and urgent action is critical to mitigate its impact.

World first cross-industry initiative launches in the continued fight against antimicrobial resistance

We are incredibly proud to be partnering with NHS England, NICE and the UK government in piloting an innovative reimbursement model for antimicrobials. 

PP-UNP-GBR-2799 / January 2023
Science Products Responsibility PartnershipsCareers Privacy Statement Terms of Use Contact UsSitemap Copyright © 2017-2024 Pfizer Limited. PP-UNP-GBR-8108 / January 2024. All rights reserved. Registered in England and Wales No. 526209. Registered office: Ramsgate Road, Sandwich, Kent CT13 9NJ. VAT No. GB201048427. This website is intended for the general public in the UK.